Stoke Therapeutics, Inc. - COM (STOK)

Historical Portfolio Holders from Q2 2019 to Q3 2024

All holders as of September 30, 2024
Q3 2024
Type / Class
Equity / COM
Shares, excl. options Q3 2024
58.2M
Holdings value Q3 2024
$716M
Value change Q3 2024
-$45.8M
Grand Portfolio weight change Q3 2024
0%
Number of holders
116
Number of buys Q3 2024
58
Number of sells Q3 2024
-55
Average buys Q3 2024 %
+0.001%
Average sells Q3 2024 %
-0.003%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q3 58.2M $716M -$45.8M $12.29 117
2024 Q2 61.3M $828M +$97.1M $13.51 115
2024 Q1 54.1M $730M +$123M $13.50 103
2023 Q4 45M $237M +$6.78M $5.26 81
2023 Q3 43.9M $173M -$18.5M $3.94 97
2023 Q2 46.5M $495M +$21M $10.63 98
2023 Q1 44.6M $372M +$35.3M $8.33 97
2022 Q4 40.3M $372M -$22.6M $9.23 106
2022 Q3 42.3M $544M -$11.7M $12.84 101
2022 Q2 43.1M $569M +$19.6M $13.21 90
2022 Q1 41.3M $870M +$124M $21.05 98
2021 Q4 35.4M $848M +$26.3M $23.99 90
2021 Q3 19.3M $492M -$30.8M $25.44 88
2021 Q2 20.2M $680M -$703M $33.66 96
2021 Q1 38.4M $1.49B -$15.7M $38.84 104
2020 Q4 38.6M $2.39B +$252M $61.93 95
2020 Q3 34.6M $1.16B +$2.94M $33.49 91
2020 Q2 34.9M $825M +$9.8M $23.83 71
2020 Q1 34.6M $791M +$23.4M $22.90 67
2019 Q4 33.5M $948M +$22.4M $28.32 64
2019 Q3 15.9M $339M +$30.1M $21.49 52
2019 Q2 14.2M $409M +$409M $29.17 47